Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2025)

Historic Receivables - Net for X4 Pharmaceuticals (XFOR) over the last 3 years, with Q3 2025 value amounting to $891000.0.

  • X4 Pharmaceuticals' Receivables - Net changed N/A to $891000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $891000.0, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • X4 Pharmaceuticals' Receivables - Net amounted to $891000.0 in Q3 2025.
  • Over the past 5 years, X4 Pharmaceuticals' Receivables - Net peaked at $1.1 million during Q2 2025, and registered a low of $509000.0 during Q1 2025.